2023 annual financial data
Seres Therapeutics 2023 Net margin
Direct answer
Net margin was -90.02%.
Operating income was -195.1M USD and net income was -113.72M USD.
Operating cash flow was -117.35M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 126.33M USD
- Operating income
- -195.1M USD
- Net income
- -113.72M USD
- Operating cash flow
- -117.35M USD